This laboratory finding helps to differentiate acquired bradykinin-mediated angioedema from hereditary angioedema (HEA) type I or type II, which is caused by a mutation in the SERPING1 gene encoding C1-INH and therefore will presented with low levels of C1-INH and C4 (15, 16). The gene discussed is C4A; the disease is hereditary angioedema.